Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03822052
Other study ID # ME 19 004
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2019
Est. completion date December 19, 2019

Study information

Verified date December 2019
Source Ascension Genesys Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Currently, the optimum IV fluid for induction of labor is unknown. The goal of this study is to determine the optimum fluid for induction of labor, D5LR versus LR. The investigators hypothesize that patients assigned to the D5LR group will have a shorter induction of labor when compared to patient's in the LR group.


Description:

Induction of labor is increasingly common in the United States, as the overall rate has increased from 9.5% in 1990 to 22.1% in 2006 with the goal to stimulate contractions prior to the onset of spontaneous labor. Cesarean delivery rates are also at an all-time high in the U.S., with more than 32% of patients being delivered by Cesarean in 2009. One of the most common indications for Cesarean section is a prolonged labor course. Patient's with a prolonged labor course are also at risk for infections, including chorioamnionitis and endometritis, as well as an increased risk of postpartum hemorrhage. There is a lack of information on ways to help shorten labor to potentially minimize these risks.

The uterus is comprised of skeletal muscle, and labor has been likened to prolonged rigorous exercise. While oral hydration has been endorsed by ACOG for low-risk women in spontaneous labor, solid foods should be avoided. In turn, women with a prolonged induction or labor may benefit from glucose supplementation via IV fluids.

The DEXTRONS study, J. Pare et al., looked at supplementation of D5LR versus normal saline in nulliparous patients who presented for a favorable induction of labor. This study showed a significant reduction in active labor time in the D5LR group versus the normal saline group.

Currently, at Genesys Regional Medical Center, lactated ringers is the preferred IV fluid for patients presenting for induction of labor. This study will randomly assign patients to D5LR versus lactated ringers and examine the length of time from induction to delivery to determine if glucose supplementation has an effect on reducing length of induction in both nulliparous and multiparous patients for either a favorable induction of labor or an induction for post-dates. Secondary outcomes will include Apgar scores, need for special care nursery/NICU admissions, and mode of delivery. The study will begin in January 2019 and continue through July 2019. Patients who presented to labor and delivery and consent to be included in the study will be randomized to each group.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date December 19, 2019
Est. primary completion date November 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Pregnant women, age 18 - 45, that were admitted for induction of labor without any co-morbid conditions and their respective newborns with

- Induction of labor

- Singleton pregnancies

- Vertex presentation

- Pregnancies at 39 0/7 weeks gestation - 41 6/7 weeks gestation

- All races/ethnicities

Exclusion Criteria:

- Multifetal gestations

- Noncephalic presentation

- Preexisting medical conditions:

- Maternal cardiac disease

- Lung diseases

- Chronic hypertension

- Pregestational or gestational diabetes

- gHTN or Pre-Eclampsia

- medical indication for induction of labor (olighydramnios, IUGR)

Study Design


Related Conditions & MeSH terms

  • Induction of Labor Affected Fetus / Newborn

Intervention

Other:
Lactated ringers
IV fluid
5% dextrose lactated ringers
IV fluid

Locations

Country Name City State
United States Ascension Genesys Hospital Grand Blanc Michigan

Sponsors (1)

Lead Sponsor Collaborator
Ascension Genesys Hospital

Country where clinical trial is conducted

United States, 

References & Publications (8)

ACOG Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-97. doi: 10.1097/AOG.0b013e3181b48ef5. Review. — View Citation

ACOG Committee Opinion No. 761: Cesarean Delivery on Maternal Request. Obstet Gynecol. 2019 Jan;133(1):e73-e77. doi: 10.1097/AOG.0000000000003006. — View Citation

ACOG Committee Opinion No. 766: Approaches to Limit Intervention During Labor and Birth. Obstet Gynecol. 2019 Feb;133(2):e164-e173. doi: 10.1097/AOG.0000000000003074. — View Citation

Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186. doi: 10.1097/AOG.0000000000002351. — View Citation

Fong A, Serra AE, Caballero D, Garite TJ, Shrivastava VK. A randomized, double-blinded, controlled trial of the effects of fluid rate and/or presence of dextrose in intravenous fluids on the labor course of nulliparas. Am J Obstet Gynecol. 2017 Aug;217(2):208.e1-208.e7. doi: 10.1016/j.ajog.2017.03.010. Epub 2017 Mar 18. — View Citation

Paré J, Pasquier JC, Lewin A, Fraser W, Bureau YA. Reduction of total labor length through the addition of parenteral dextrose solution in induction of labor in nulliparous: results of DEXTRONS prospective randomized controlled trial. Am J Obstet Gynecol. 2017 May;216(5):508.e1-508.e7. doi: 10.1016/j.ajog.2017.01.010. Epub 2017 Jan 30. — View Citation

Philipson EH, Kalhan SC, Riha MM, Pimentel R. Effects of maternal glucose infusion on fetal acid-base status in human pregnancy. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):866-73. — View Citation

Sharma C, Kalra J, Bagga R, Kumar P. A randomized controlled trial comparing parenteral normal saline with and without 5% dextrose on the course of labor in nulliparous women. Arch Gynecol Obstet. 2012 Dec;286(6):1425-30. doi: 10.1007/s00404-012-2485-1. Epub 2012 Aug 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Time of induction Time from start of labor induction to delivery of infant 492 min +/- 35 min
Secondary Time of Active Labor time from 6 cm dilation until delivery of infant 4 hours +/- 3 hours
Secondary Apgar Scores validated measure of infant health 492 min +/- 35 min
Secondary Mode of Delivery Cesarean section vs SVD vs OVD 492 min +/- 35 min
Secondary Neonatal ICU admissions ICU or special care nursery admissions 24 hours after delivery
Secondary Need for respiratory support Neonatal need for respiratory support 24 hours after delivery
Secondary Transfer to tertiary care center neonatal need for transfer to higher level NICU 24 hours after delivery
See also
  Status Clinical Trial Phase
Recruiting NCT04492150 - Effect of Glucose 5% on Labor Length N/A
Not yet recruiting NCT03625518 - Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes Early Phase 1
Completed NCT04496908 - Early Versus Delayed Artificial Rupture of Membranes (AROM Trial) Early Phase 1
Recruiting NCT04478942 - PROMMO Trial: Oral Misoprostol vs IV Oxytocin Early Phase 1
Completed NCT04597333 - Labor Induction After Failed Induction With Dinoprostone. N/A
Completed NCT03682718 - Vaginal Misoprostol With Intracervical Foley Catheter in Induction of Labor Phase 4
Recruiting NCT03533699 - A Comparison Between the Effect of Oxytocin Only and Oxytocin Plus Propranolol on Induction of Labor in Term Pregnancy N/A
Recruiting NCT05187247 - VR Glasses During Induction of Labour for Pain and Anxiety Relieve N/A
Active, not recruiting NCT02975167 - Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor N/A
Recruiting NCT05079841 - The Stimulation To Induce Mothers Study Phase 4
Not yet recruiting NCT06375746 - The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve - a Randomized Controlled Trial Phase 3
Completed NCT04220320 - The Success of Labor Induction Based on a Modified BISHOP Score.
Withdrawn NCT04739683 - Cervical Ripening With Foley Bulb Versus Dilapan-S at Home N/A
Completed NCT03086967 - Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours N/A
Completed NCT04299854 - Modality of Induction of Labor in Obese Women at Term (MODOBAT)
Completed NCT03944187 - Sonographic Assessment for Prediction of Labor Induction Success
Recruiting NCT03928899 - The Best Timing of Delivery in Women With GDM Study N/A
Not yet recruiting NCT04350437 - Induction Of Labor: Predictors of Outcomes N/A
Terminated NCT04011098 - Improving Labour Induction Analgesia: Epidural Fentanyl Bolus at Epidural Initiation for Induction of Labour Phase 1
Completed NCT02952807 - Vaginal Misoprostol and Foley Catheter for Induction of Labor Phase 2